A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis

Journal of the American College of Surgeons

Volumn 212, Issue 3, 2011, Pages 340-348

  Koyama, Taro ^a,b   Hackl, Florian ^a,b   Aflaki, Pejman ^a,b   Bergmann, Juri ^a,b   Zuhaili, Baraa ^a,b   Waisbren, Emily ^a,b   Govindarajulu, Usha ^a   Yao, Feng ^a,b   Eriksson, Elof ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CELL MIGRATION; EPITHELIZATION; EX VIVO GENE TRANSFER; FEMALE; FULL THICKNESS SKIN GRAFT; GENE EXPRESSION; GENETIC ENGINEERING; IN VITRO GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN TRANSPLANTATION; SPLIT THICKNESS SKIN GRAFT; SWINE; WOUND; WOUND FLUID;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN TRANSPLANTATION; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 79952314294     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.10.017     Document Type: Article

References (33)

1. Andree C, Swain WF, Page CP, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci U S A 1994;91:12188-12192.
2. Eriksson E, Yao F, Svensjo T, et al. In vivo gene transfer to skin and wound by microseeding. J Surg Res 1998;78:85-91.
3. Hirsch T, Spielmann M, Velander P, et al. Insulin-like growth factor-1 gene therapy and cell transplantation in diabetic wounds. J Gene Med 2008;10:1247-1252.
4. Svensjo T, Yao F, Pomahac B, et al. Cultured autologous fibroblasts augment epidermal repair. Transplantation 2002;73: 1033-1041. (Pubitemid 34415431)
5. Velander P, Theopold C, Hirsch T, et al. Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia. Wound Repair Regen 2008;16:288-293. (Pubitemid 351342136)
6. Vogt PM, Thompson S, Andree C, et al. Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci U S A 1994;91:9307-9311. (Pubitemid 24297903)
7. Vranckx JJ, Hoeller D, Velander PE, et al. Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor. Wound Repair Regen 2007;15:657-664. (Pubitemid 47493884)
8. Vranckx JJ, Yao F, Petrie N, et al. In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen 2005;13:51-60.
9. Yao F, Svensjo T, Winkler T, et al. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 1998;9:1939-1950. (Pubitemid 28439099)
10. Nystrom G. Sowing of small skin graft particles as a method for epithelization especially of extensive wound surfaces. Plast Reconstr Surg Transplant Bull 1959;23:226-239.
11. Cox WA, Nichol WW. Evaluation of the fine-particle skin autograft technique. AMA Arch Surg 1958;77:870-874.
12. Lin TW, Horng SY. A new method of microskin mincing. Burns 1994;20:526-528.
13. Najarian JS, Crane JT, McCorkle HJ. An experimental study of the grafting of a suspension of skin particles. Surgery 1957;42: 218-227.
14. Svensjo T, Pomahac B, Yao F, et al. Autologous skin transplantation: comparison of minced skin to other techniques. J Surg Res 2002;103:19-29. (Pubitemid 34953387)
15. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007;127:998-1008. (Pubitemid 46625161)
16. Davidson JM. First-class delivery: getting growth factors to their destination. J Invest Dermatol 2008;128:1360-1362. (Pubitemid 351693218)
17. Williams DA. ESCGT 2008: progress in clinical gene therapy. Mol Ther 2009;17:1-2.
18. Morgan JR, Barrandon Y, Green H, Mulligan RC. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987;237:1476-1479. (Pubitemid 17125441)
19. Teumer J, Lindahl A, Green H. Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB J 1990;4:3245-3250. (Pubitemid 120012571)
20. Eming SA, Lee J, Snow RG, et al. Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice - implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 1995;105:756-763. (Pubitemid 26005599)
21. Eming SA, Medalie DA, Tompkins RG, et al. Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 1998; 9:529-539. (Pubitemid 28149606)
22. Escamez MJ, Garcia M, Larcher F, et al. An in vivo model of wound healing in genetically modified skin-humanized mice. J Invest Dermatol 2004;123:1182-1191. (Pubitemid 39586844)
23. Hao L, Wang J, Zou Z, et al.Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury. Gene Ther 2009;16:34-42.
24. Dickens S, Vermeulen P, Hendrickx B, et al. Regulable vascular endothelial growth factor(165) overexpression by ex vivo expanded keratinocyte cultures promotes matrix formation, angiogenesis, and healing in porcine full-thickness wounds.Tissue Eng Part A 2008;14:19-27.
25. Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen 2001; 9:66-76. (Pubitemid 32463294)
26. Weinstein GD. Autoradiographic studies on turnover time and protein synthesis in pig epidermis. J Invest Dermatol 1965;44: 413-419.
27. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-964. (Pubitemid 28101786)
28. Berse B, Brown LF, Van deWater L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-220.
29. Gaudry M, Bregerie O, Andrieu V, et al. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997;90:4153-4161. (Pubitemid 27484071)
30. Jazwa A, Loboda A, Golda S, et al. Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. Free Radic Biol Med 2006;40:1250-1263.
31. Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452. (Pubitemid 28275003)
32. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-1309. (Pubitemid 20066716)
33. Stojadinovic O, Kodra A, Golinko M, et al. A novel, nonangiogenic mechanism of VEGF: Stimulation of keratinocyte and fibroblast migration.Wound Repair Regen 2007;15:A30.